Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)

被引：2
|
作者：
Kawabe, K
机构：
[1] Department of Urology, Faculty of Medicine, The University of Tokyo, Tokyo
来源：
AKTUELLE UROLOGIE | 1996年 / 27卷
关键词：
BPH; alpha-blocker; alpha(1a)-receptor-subtype; tamsulosin;
D O I：
10.1055/s-2008-1055642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical trials of tamsulosin demonstrate that it is an effective treatment modality for the symptoms associated with BPH, and it has practically no effect on blood pressure at a dose of 0.2 mg. This is probably due to its selective affinity for the prostate, which may be due to the strong affinity of tamsulosin for the alpha(1a)-receptor subtype.
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [41] A Review of Laser Treatment for Symptomatic BPH (Benign Prostatic Hyperplasia)
    Nair, Shiva Madhwan
    Pimentel, Marie Adrianne
    Gilling, Peter John
    CURRENT UROLOGY REPORTS, 2016, 17 (06)
  • [42] TRANSPERINEAL LASER ABLATION FOR BENIGN PROSTATIC HYPERPLASIA (BPH): FEASIBILITY AND SAFETY
    Bianco, Fernando
    Lopez-Prieto, Alberto
    Luna, Eusebio
    Luis, Avila
    Gheiler, Edward
    Kaufman, Ariel
    Cohen, David
    JOURNAL OF UROLOGY, 2021, 206 : E450 - E450
  • [43] Effect of the alpha-1 adrenoceptor blocker on tissue norepinephrine contents in human benign prostatic hyperplasia
    Ishigooka M.
    Hayami S.
    Hashimoto T.
    Suzuki Y.
    Ichiyanagi O.
    Nakada T.
    International Urology and Nephrology, 1997, 29 (2) : 195 - 200
  • [44] Herbal drugs for treatment of benign prostate hyperplasia (BPH).
    Schilcher, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 89 - AGFD
  • [45] Alpha–1–adrenoceptor blockade in the treatment of benign prostatic hyperplasia
    F Lowe
    Prostate Cancer and Prostatic Diseases, 1999, 2 : 110 - 119
  • [46] Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia
    Ichioka, K
    Ohara, H
    Terada, N
    Matsui, Y
    Yoshimura, K
    Terai, A
    Arai, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (10) : 870 - 875
  • [47] Tamsulosin and Solifenacin in the treatment of Benign Prostatic Hyperplasia in combination with overactive bladder
    Wang, Hui
    Chang, Yanhua
    Liang, Hui
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (04) : 988 - 992
  • [48] Comparison of a phytotherapeutic agent (Permixon) with an α-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia:: A 1-year randomized international study -: Comment
    Fitzpatrick, JM
    EUROPEAN UROLOGY, 2002, 41 (05) : 506 - 506
  • [49] Editorial Comment to Tamsulosin versus transurethral resection of the prostate: Effect on nocturia due to benign prostatic hyperplasia
    Milicevic, Snjezana
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (03) : 248 - 249
  • [50] Benign prostatic hyperplasia and prostate-specific antigen
    Pejcic, Tomislav
    Acimovic, Miodrag
    Dzamic, Zoran
    Radovanovic, Milan
    Hadzi-Djokic, Jovan
    VOJNOSANITETSKI PREGLED, 2015, 72 (05) : 447 - 453
12345